1.Gupta G. P. and Massague. J. (2006) Cancer
metastasis: building a
framework. Cell 127(4): 679-695.
2. Belpomme D., Irigaray P., Sasco A. J.,
Newby J. A., Howard V., Clapp. R. and
Hardell. L. (2007) The growing incidence of
cancer: Role of lifestyle and screening
detection (Review). International journal of oncology 30(5): 1037-1049.
3. Jin H., Liang Y., Wang X., Zhu J., Sun R.,
Chen P., Nie X., Gao. L. and Zhang. L.
(2014) Association between a functional
polymorphism rs712 within let-7-binding
site and risk of papillary thyroid
cancer. Medical Oncology 31(10): 1-5.
4. World Health Organization (2007) Cancer
control: knowledge into action: WHO guide
for effective programmes: WHO
5. Mishan M. A., Heirani-Tabasi A.,
Mokhberian N., Hassanzade M.,
Moghaddam H. K., Bahrami. A. R. and
Ahmadiankia. N. (2015) Analysis of
Chemokine Receptor Gene Expression in
Esophageal Cancer Cells Compared with
Breast Cancer with Insights into
Metastasis. Iranian journal of public
health 44(10):1353.
6. Subramanian A. P., Jaganathan S. K. and
Supriyanto E. (2015). Overview on in vitro
and in vivo investigations of nanocomposite
based cancer diagnosis and therapeutics.
RSC Advances 5(89): 72638-72652.
7. Mishan M. A., Ahmadiankia. N. and
Bahrami. A. R. (2016). CXCR4 and CCR7 Two eligible targets in targeted cancer
therapy. Cell biology international